<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0">
	<channel>
		<lastBuildDate>Fri, 29 Aug 2008 11:09:37 -0400</lastBuildDate>
		<title>PeerView CME/CE Video Podcast - AIDS/HIV</title>
		<itunes:author>PeerView Press</itunes:author>
		<link>http://www.peerviewpress.com</link>
		<generator>Podcast Maker v1.3.3 - http://www.lemonzdream.com/podcastmaker</generator>
		<description>PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.</description>
		<itunes:subtitle>Thought leader perspectives on current clinical advances in medicine.</itunes:subtitle>
		<itunes:summary>PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.</itunes:summary>
		<language />
		<copyright>2007</copyright>
		<itunes:owner>
			<itunes:name>PeerView Press, 24 West 40th Street, Suite 950, New York, NY 10018</itunes:name>
			<itunes:email>webmaster@peerviewpress.com</itunes:email>
		</itunes:owner>
		<image>
			<url>http://podcast.peerviewpress.com/aidsvideo/vidAIDS-HIV-CME_CE_art_QAapp_160307_144.jpg</url>
			<title>PeerView CME/CE Video Podcast - AIDS/HIV</title>
			<link>http://www.peerviewpress.com</link>
			<width>144</width>
			<height>144</height>
		</image>
		<itunes:image href="http://podcast.peerviewpress.com/aidsvideo/vidAIDS-HIV-CME_CE_art_QAapp_160307.jpg" />
		<category>Science &amp; Medicine</category>
		<itunes:category text="Science &amp; Medicine" />
		<itunes:keywords>CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, AIDS, HIV</itunes:keywords>
		<itunes:explicit>no</itunes:explicit>
		<item>
			<title>David Wohl, MD - When HAART Fails: The Role of Adherence in Successful HIV Therapy</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, experts in the treatment of HIV discuss the importance of treatment adherence for patients with this condition. Factors associated with nonadherence are explored, and strategies to improve adherence are highlighted.</description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV discuss the importance of treatment adherence for patients with this condition. Factors associated with nonadherence are explored, and strategies to improve adherence are highlighted.</itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA04263FCr408.m4v" length="33109574" />
			<link>http://podcast.peerviewpress.com/aidsvideo/PA04263FCr408.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA04263FCr408.m4v</guid>
			<pubDate>Fri, 29 Aug 2008 11:02:03 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:22:20</itunes:duration>
			<itunes:keywords>Adherence, antiretrovirals, PI, NNRTI, NRTI, pill burden, regimen complexity, forgiveness, food, alcohol</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - When HAART Fails: The Role of Adherence in Successful HIV Therapy</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA04263FCCMEinfo.pdf" length="531831" />
			<link>http://podcast.peerviewpress.com/aidsvideo/PA04263FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA04263FCCMEinfo.pdf</guid>
			<pubDate>Fri, 29 Aug 2008 11:02:01 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>Adherence, antiretrovirals, PI, NNRTI, NRTI, pill burden, regimen complexity, forgiveness, food, alcohol</itunes:keywords>
		</item>
		<item>
			<title>W. David Hardy, MD - Advances in the Use of NNRTI-Based Treatment in HIV: Optimizing Patient Management</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, experts evaluate recent data on the efficacy and safety of NNRTI-based regimens for treatment-naïve patients with HIV. An analysis of how patient-related and medication-related factors play a role in selecting initial NNRTI-based regimens is featured.</description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts evaluate recent data on the efficacy and safety of NNRTI-based regimens for treatment-naïve patients with HIV. An analysis of how patient-related and medication-related factors play a role in selecting initial NNRTI-based regimens is featured.</itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA04427FCr401.m4v" length="34726479" />
			<link>http://podcast.peerviewpress.com/aidsvideo/PA04427FCr401.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA04427FCr401.m4v</guid>
			<pubDate>Tue, 17 Jun 2008 11:14:17 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:20:41</itunes:duration>
			<itunes:keywords>AIDS, HIV, NNRTIs, DHHS, efavirenz, nevirapine, treatment-naïve, HAART</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Advances in the Use of NNRTI-Based Treatment in HIV: Optimizing Patient Management</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA04427FCCMEinfo.pdf" length="288047" />
			<link>http://podcast.peerviewpress.com/aidsvideo/PA04427FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA04427FCCMEinfo.pdf</guid>
			<pubDate>Tue, 17 Jun 2008 11:11:45 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, NNRTIs, DHHS, efavirenz, nevirapine, treatment-naïve, HAART</itunes:keywords>
		</item>
		<item>
			<title>William A. O&apos;Brien, MD - Maintaining Optimal Virologic Suppression in HIV: When and How to Switch Antiretroviral Regimens</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, experts in the treatment of HIV discuss recent issues on when to initiate antiretroviral agents and how and when to switch therapy.</description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV discuss recent issues on when to initiate antiretroviral agents and how and when to switch therapy.</itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA04259FCe019.m4v" length="56175089" />
			<link>http://podcast.peerviewpress.com/aidsvideo/PA04259FCe019.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA04259FCe019.m4v</guid>
			<pubDate>Fri, 30 May 2008 10:07:13 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:40:10</itunes:duration>
			<itunes:keywords>AIDS, HIV, treatment failure, virologic failure, immunologic failure, clinical progression, PI, NNRTI</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Maintaining Optimal Virologic Suppression in HIV: When and How to Switch Antiretroviral Regimens</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA04259FCCMEinfo.pdf" length="298247" />
			<link>http://podcast.peerviewpress.com/aidsvideo/PA04259FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA04259FCCMEinfo.pdf</guid>
			<pubDate>Fri, 30 May 2008 10:07:10 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, treatment failure, virologic failure, immunologic failure, clinical progression, PI, NNRTI</itunes:keywords>
		</item>
		<item>
			<title>Calvin Cohen, MD, MSc - Advances in HIV Management: An Update From Boston</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, experts in the treatment of HIV present recent data on the efficacy and safety of a number of antiretroviral regimens used in the management of treatment-naïve patients. A discussion on the clinical implications of updated DHHS guidelines for the initiation of treatment is featured.</description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present recent data on the efficacy and safety of a number of antiretroviral regimens used in the management of treatment-naïve patients. A discussion on the clinical implications of updated DHHS guidelines for the initiation of treatment is featured.</itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA04181FCs474.m4v" length="25612950" />
			<link>http://podcast.peerviewpress.com/aidsvideo/PA04181FCs474.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA04181FCs474.m4v</guid>
			<pubDate>Wed, 30 Apr 2008 14:40:48 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:30:08</itunes:duration>
			<itunes:keywords>AIDS, HIV, DHHS, CROI, lipoatrophy, SMART, CASTLE, M05-730, ACTG 5142</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Advances in HIV Management: An Update From Boston</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA04181FCCMEinfo.pdf" length="273994" />
			<link>http://podcast.peerviewpress.com/aidsvideo/PA04181FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA04181FCCMEinfo.pdf</guid>
			<pubDate>Wed, 30 Apr 2008 14:40:48 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, DHHS, CROI, lipoatrophy, SMART, CASTLE, M05-730, ACTG 5142</itunes:keywords>
		</item>
		<item>
			<title>Daniel R. Kuritzkes, MD - Integrating New and Emerging Agents in HIV: An Update From Boston</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of new agents for the management of treatment-experienced patients with HIV.</description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of new agents for the management of treatment-experienced patients with HIV.</itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA04547FCr381.m4v" length="37102365" />
			<link>http://podcast.peerviewpress.com/aidsvideo/PA04547FCr381.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA04547FCr381.m4v</guid>
			<pubDate>Thu, 17 Apr 2008 13:18:36 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:28:40</itunes:duration>
			<itunes:keywords>AIDS, HIV, CROI, raltegravir, maraviroc, etravirine, CCR5, DUET, BENCHMRK, MOTIVATE, tropism assay, treatment-experienced</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Integrating New and Emerging Agents in HIV: An Update From Boston</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA04547FCCMEinfo.pdf" length="208426" />
			<link>http://podcast.peerviewpress.com/aidsvideo/PA04547FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA04547FCCMEinfo.pdf</guid>
			<pubDate>Thu, 17 Apr 2008 13:18:33 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, CROI, raltegravir, maraviroc, etravirine, CCR5, DUET, BENCHMRK, MOTIVATE, tropism assay, treatment-experienced</itunes:keywords>
		</item>
		<item>
			<title>William A. O&apos;Brien, MD - Individualized Therapy for Treatment-Naïve Patients With HIV: What To Use and When To Initiate</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, experts in the management of HIV review important issues to consider when individualizing antiretroviral therapy. The treatment of patients with HIV and comorbid HBV, HCV, or renal insufficiency, as well as management strategies for pregnant women are featured.</description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the management of HIV review important issues to consider when individualizing antiretroviral therapy. The treatment of patients with HIV and comorbid HBV, HCV, or renal insufficiency, as well as management strategies for pregnant women are featured.</itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA04154FCe011.m4v" length="30519118" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA04154FCe011.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA04154FCe011.m4v</guid>
			<pubDate>Tue, 08 Apr 2008 11:11:25 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:34:52</itunes:duration>
			<itunes:keywords>AIDS, HIV, DHHS, atazanavir, lopinavir, efavirenz, nevirapine, pregnancy, hepatitis, coinfection, zidovudine, lamivudine</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Individualized Therapy for Treatment-Naïve Patients With HIV: What To Use and When To Initiate</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA04154FCCMEinfo.pdf" length="282784" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA04154FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA04154FCCMEinfo.pdf</guid>
			<pubDate>Tue, 08 Apr 2008 11:10:22 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, DHHS, atazanavir, lopinavir, efavirenz, nevirapine, pregnancy, hepatitis, coinfection, zidovudine, lamivudine</itunes:keywords>
		</item>
		<item>
			<title>Kathleen Squires, MD - Considerations for Managing HIV in Women</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, experts in the treatment of HIV present important issues regarding the management of HIV in women. The treatment of HIV in pregnant women is featured.</description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present important issues regarding the management of HIV in women. The treatment of HIV in pregnant women is featured.</itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA04268FCr389.m4v" length="20651847" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA04268FCr389.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA04268FCr389.m4v</guid>
			<pubDate>Fri, 28 Mar 2008 15:47:42 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:23:12</itunes:duration>
			<itunes:keywords>HIV, pregnancy, contraception, DHHS, efavirenz, nelfinavir, antitretrovirals, mother-to-child transmission, zidovudine</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Considerations for Managing HIV in Women</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA04268FCCMEinfo.pdf" length="224257" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA04268FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA04268FCCMEinfo.pdf</guid>
			<pubDate>Fri, 28 Mar 2008 15:47:41 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>HIV, pregnancy, contraception, DHHS, efavirenz, nelfinavir, antitretrovirals, mother-to-child transmission, zidovudine</itunes:keywords>
		</item>
		<item>
			<title>Eric Daar, MD - Updated DHHS Guidelines for HIV: Incorporating Recent Updates Into Clinical Practice</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, experts in the treatment of HIV assess the most recent updates to the DHHS guidelines on HIV management and discuss how these recommendations should be implemented into clinical practice. </description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV assess the most recent updates to the DHHS guidelines on HIV management and discuss how these recommendations should be implemented into clinical practice. </itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA03620FC3CMEinfo.pdf" length="273232" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03620FC3r360.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03620FC3CMEinfo.pdf</guid>
			<pubDate>Wed, 27 Feb 2008 12:37:20 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, DHHS, guidelines,CD4 counts, abacavir, atazanavir, lopinavir, efavirenz, tipranavir, darunavir, etravirine, nelfinavir, fosamprenavir, resistance testing, genotype, haplotype, hepatitis B coinfection, pregnancy</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Updated DHHS Guidelines for HIV: Incorporating Recent Updates Into Clinical Practice</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA03620FC3r360.m4v" length="14266731" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03620FC3CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03620FC3r360.m4v</guid>
			<pubDate>Wed, 27 Feb 2008 12:37:20 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:15:50</itunes:duration>
			<itunes:keywords>AIDS, HIV, DHHS, guidelines,CD4 counts, abacavir, atazanavir, lopinavir, efavirenz, tipranavir, darunavir, etravirine, nelfinavir, fosamprenavir, resistance testing, genotype, haplotype, hepatitis B coinfection, pregnancy</itunes:keywords>
		</item>
		<item>
			<title>W. David Hardy, MD - Optimizing Initial Antiretroviral Therapy: PI- Versus NNRTI-based Regimens</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, an expert in the treatment of HIV will examine key issues to consider when choosing an initial antiretroviral strategy. </description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.	</itunes:subtitle>
			<itunes:summary>In this activity, an expert in the treatment of HIV will examine key issues to consider when choosing an initial antiretroviral strategy. </itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA03539FC2p130.m4v" length="44322337" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03539FC2p130.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03539FC2p130.m4v</guid>
			<pubDate>Tue, 15 Jan 2008 13:40:31 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:52:16</itunes:duration>
			<itunes:keywords>AIDS, HIV, NNRTI, PI, zidovudine, lamivudine, tenofovir, emtricitabine, abacavir, efavirenz, nevirapine, atazanavir, lopinavir, fosamprenavir, darunavir, ritonavir, treatment-naïve, 2NN, DHHS, IAS-USA</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Optimizing Initial Antiretroviral Therapy: PI- Versus NNRTI-based Regimens</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. </description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. </itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA03539FC2CMEinfo.pdf" length="284175" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03539FC2CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03539FC2CMEinfo.pdf</guid>
			<pubDate>Tue, 15 Jan 2008 13:39:31 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, NNRTI, PI, zidovudine, lamivudine, tenofovir, emtricitabine, abacavir, efavirenz, nevirapine, atazanavir, lopinavir, fosamprenavir, darunavir, ritonavir, treatment-naïve, 2NN, DHHS, IAS-USA</itunes:keywords>
		</item>
		<item>
			<title>Ian Frank, MD - Update from IAS, ICAAC &amp; IDSA: Focus on New and Emerging HIV Therapies</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of new and emerging antiretroviral agents. 


</description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.	</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of new and emerging antiretroviral agents. 


</itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA04089FCs437.m4v" length="29989604" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA04089FCs437.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA04089FCs437.m4v</guid>
			<pubDate>Mon, 14 Jan 2008 09:20:02 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:34:34</itunes:duration>
			<itunes:keywords>AIDS, HIV, maraviroc, vicriviroc, raltegravir, elvitegravir, etravirine, TMC125, rilpivirine, TMC278, treatment experienced, CCR5, integrase inhibitors, ICAAC, IDSA, IAS, CXCR4, dual/mixed tropic, darunavir</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information -  Update from IAS, ICAAC &amp; IDSA: Focus on New and Emerging HIV Therapies</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA04089FCCMEinfo.pdf" length="218122" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA04089FCCMECEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA04089FCCMEinfo.pdf</guid>
			<pubDate>Mon, 14 Jan 2008 09:20:01 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, maraviroc, vicriviroc, raltegravir, elvitegravir, etravirine, TMC125, rilpivirine, TMC278, treatment experienced, CCR5, integrase inhibitors, ICAAC, IDSA, IAS, CXCR4, dual/mixed tropic, darunavir</itunes:keywords>
		</item>
		<item>
			<title>William A. O’Brien, MD - Long-Term Safety and Durability of Fixed-Dose Antiretroviral Regimens: A Case-Based Approach</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, an expert in the treatment of HIV uses a case-based method to discuss the most recent data on the safety and efficacy of fixed-dose antiretrovirals.</description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.	</itunes:subtitle>
			<itunes:summary>In this activity, an expert in the treatment of HIV uses a case-based method to discuss the most recent data on the safety and efficacy of fixed-dose antiretrovirals.</itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA03903FCp133.m4v" length="37621387" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03903FCp133.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03903FCp133.m4v</guid>
			<pubDate>Fri, 21 Dec 2007 09:44:10 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:35:00</itunes:duration>
			<itunes:keywords>CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, AIDS, HIV</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Long-Term Safety and Durability of Fixed-Dose Antiretroviral Regimens: A Case-Based Approach</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA03903FCCMECEinfo.pdf" length="344813" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03903FCCMECEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03903FCCMECEinfo.pdf</guid>
			<pubDate>Fri, 21 Dec 2007 09:44:06 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, AIDS, HIV</itunes:keywords>
		</item>
		<item>
			<title>Kathleen Squires, MD - Challenges in HIV Therapy: Initial Options and Switching Strategies</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, experts in the treatment of HIV present current data on initial treatment options in HIV as well as efficacy and safety data on switching strategies.</description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present current data on initial treatment options in HIV as well as efficacy and safety data on switching strategies.</itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA03538FC3s429.m4v" length="18009300" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03538FC3r429.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03538FC3s429.m4v</guid>
			<pubDate>Fri, 07 Dec 2007 15:45:57 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:20:36</itunes:duration>
			<itunes:keywords>AIDS, HIV, antiretroviral, efavirenz, tenofovir, emtricitabine, zidovudine, lamivudine, atazanavir, fosamprenavir, lopinavir, ritonavir, darunavir, maraviroc, raltegravir, stavudine, abacavir, integrase inhibitor, CD4, DHHS, IAS-USA, cholesterol, LDL, HDL</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Challenges in HIV Therapy: Initial Options and Switching Strategies</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA03538FC3CMEinfo.pdf" length="241953" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03538FC3CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03538FC3CMEinfo.pdf</guid>
			<pubDate>Fri, 07 Dec 2007 15:44:57 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, antiretroviral, efavirenz, tenofovir, emtricitabine, zidovudine, lamivudine, atazanavir, fosamprenavir, lopinavir, ritonavir, darunavir, maraviroc, raltegravir, stavudine, abacavir, integrase inhibitor, CD4, DHHS, IAS-USA, cholesterol, LDL, HDL</itunes:keywords>
		</item>
		<item>
			<title>Ian Frank, MD - Optimal Use of Initial Treatments and Switching Strategies in HIV</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, an expert in the treatment of HIV reviews initial treatment strategies in HIV and explores issues related to switching antiretroviral therapies.</description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, an expert in the treatment of HIV reviews initial treatment strategies in HIV and explores issues related to switching antiretroviral therapies.</itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA03539FC1p122.m4v" length="46578539" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03539FC1p122.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03539FC1p122.m4v</guid>
			<pubDate>Mon, 19 Nov 2007 16:29:58 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:55:22</itunes:duration>
			<itunes:keywords>AIDS, HIV, treatment-naïve, treatment experienced, zidovudine, lamivudine, abacavir, tenofovir, emtricitabine, atazanavir, fosamprenavir, lopinavir, darunavir, efavirenz, nevirapine, etravirine</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Optimal Use of Initial Treatments and Switching Strategies in HIV</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA03539FC1CMEinfo.pdf" length="100609" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03539FC1CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03539FC1CMEinfo.pdf</guid>
			<pubDate>Mon, 19 Nov 2007 16:29:57 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, treatment-naïve, treatment experienced, zidovudine, lamivudine, abacavir, tenofovir, emtricitabine, atazanavir, fosamprenavir, lopinavir, darunavir, efavirenz, nevirapine, etravirine</itunes:keywords>
		</item>
		<item>
			<title>Kimberly Y. Smith, MD, MPH - Evidence-Based Guidelines: Creating Maximally Suppressive Antiretroviral Regimens for Treatment-Experienced Patients With HIV</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, experts in the treatment of HIV present the most recent recommendations for creating maximally suppressive antiretroviral regimens for treatment-experienced patients with HIV.</description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present the most recent recommendations for creating maximally suppressive antiretroviral regimens for treatment-experienced patients with HIV.</itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA03620FC2r340.m4v" length="23925574" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03620FC2r340.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03620FC2r340.m4v</guid>
			<pubDate>Thu, 01 Nov 2007 14:35:53 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:21:16</itunes:duration>
			<itunes:keywords>AIDS, HIV, DHHS, treatment-experienced, atazanavir, lopinavir, efavirenz, tipranavir, darunavir, etravirine, marviroc, raltegravir, fosamprenavir, resistance testing, genotype, phenotype</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Evidence-Based Guidelines: Creating Maximally Suppressive Antiretroviral Regimens for Treatment-Experienced Patients With HIV</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA03620FC2CMEinfo.pdf" length="265907" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03620FC2CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03620FC2CMEinfo.pdf</guid>
			<pubDate>Thu, 01 Nov 2007 14:35:53 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, DHHS, treatment-experienced, atazanavir, lopinavir, efavirenz, tipranavir, darunavir, etravirine, marviroc, raltegravir, fosamprenavir, resistance testing, genotype, phenotype</itunes:keywords>
		</item>
		<item>
			<title>Donald P. Kotler, MD - Recent Perspectives on Metabolic Issues and Lipodystrophy in HIV</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, experts in the treatment of HIV present the most current data on the risk of patients with HIV developing metabolic abnormalities while on antiretroviral therapy. Treatment options to manage these abnormalities are featured.</description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present the most current data on the risk of patients with HIV developing metabolic abnormalities while on antiretroviral therapy. Treatment options to manage these abnormalities are featured.</itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA03530FCs419.m4v" length="19209128" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03530FCs419.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03530FCs419.m4v</guid>
			<pubDate>Thu, 01 Nov 2007 14:03:38 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:17:06</itunes:duration>
			<itunes:keywords>AIDS, HIV, IAS 2007, lopinavir, atazanavir, fosamprenavir, statins, body fat changes, dyslipidemia, ezetimibe, ritonavir, GEMINI, darunavir, tipranavir, limb fat, ACTG 5142, pioglitazone, SWAN</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Recent Perspectives on Metabolic Issues and Lipodystrophy in HIV</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA03530FCCMEinfo.pdf" length="238059" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03530FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03530FCCMEinfo.pdf</guid>
			<pubDate>Thu, 01 Nov 2007 14:03:37 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, IAS 2007, lopinavir, atazanavir, fosamprenavir, statins, body fat changes, dyslipidemia, ezetimibe, ritonavir, GEMINI, darunavir, tipranavir, limb fat, ACTG 5142, pioglitazone, SWAN</itunes:keywords>
		</item>
		<item>
			<title>William A. O&apos;Brien, MD - Using Fixed-Dose Antiretroviral Therapy in HIV: An Update From Sydney</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, experts in the treatment of HIV present the most current data on fixed-dose antiretroviral agents.</description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present the most current data on fixed-dose antiretroviral agents.</itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA03525FC2s422_2.m4v" length="46341518" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03525FC2s422.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03525FC2s422_2.m4v</guid>
			<pubDate>Tue, 02 Oct 2007 13:48:22 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:41:56</itunes:duration>
			<itunes:keywords>AIDS, HIV, efavirenz, atazanavir, lopinavir, fosamprenavir, tenofovir, emtricitabine, zidovudine, lamivudine, study 934, study 903, KLEAN, LAKE, SHARE, ALERT, fixed-dose, antiretrovirals</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Using Fixed-Dose Antiretroviral Therapy in HIV: An Update From Sydney</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA03525FC2CMEinfo.pdf" length="266400" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03525FC2CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03525FC2CMEinfo.pdf</guid>
			<pubDate>Tue, 02 Oct 2007 13:35:57 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, efavirenz, atazanavir, lopinavir, fosamprenavir, tenofovir, emtricitabine, zidovudine, lamivudine, study 934, study 903, KLEAN, LAKE, SHARE, ALERT, fixed-dose, antiretrovirals</itunes:keywords>
		</item>
		<item>
			<title>Calvin Cohen, MD, MSc - Optimizing New and Emerging Antiretroviral Agents in Fully Active Regimens for Treatment-Experienced Patients With HIV</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, experts in the treatment of HIV present the most current data on the efficacy and safety of newer and emerging antiretroviral agents used in the management of this condition.</description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present the most current data on the efficacy and safety of newer and emerging antiretroviral agents used in the management of this condition.</itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA03928FCr344.m4v" length="46972230" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03540FCr319.m4vhttp://podcast.peerviewpress.com/AIDSVideo/PA03540FCr319.m4vhttp://podcast.peerviewpress.com/AIDSVideo/PA03540FCr319.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03928FCr344.m4v</guid>
			<pubDate>Tue, 18 Sep 2007 15:59:51 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:39:52</itunes:duration>
			<itunes:keywords>AIDS 2007, International AIDS Conference, 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, etravirine, darunavir, tipranavir, raltegravir, maraviroc, vicriviroc, elvitegravir, HIV, AIDS, lopinavir, atazanavir, DUET</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Optimizing New and Emerging Antiretroviral Agents in Fully Active Regimens for Treatment-Experienced Patients With HIV</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA03928FCCMEinfo.pdf" length="259017" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03540FCr319.m4vhttp://podcast.peerviewpress.com/AIDSVideo/PA03540FCr319.m4vhttp://podcast.peerviewpress.com/AIDSVideo/PA03540FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03928FCCMEinfo.pdf</guid>
			<pubDate>Tue, 18 Sep 2007 15:59:48 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS 2007, International AIDS Conference, 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, etravirine, darunavir, tipranavir, raltegravir, maraviroc, vicriviroc, elvitegravir, HIV, AIDS, lopinavir, atazanavir, DUET</itunes:keywords>
		</item>
		<item>
			<title>W. David Hardy, MD - HIV in Young Adults: An Often Overlooked Epidemic</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, experts in the treatment of HIV discuss the incidence of HIV in adolescents and young adults. Management considerations for the treatment of HIV in young adults are featured.</description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV discuss the incidence of HIV in adolescents and young adults. Management considerations for the treatment of HIV in young adults are featured.</itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA03540FCr319.m4v" length="19772084" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03540FCr319.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03540FCr319.m4v</guid>
			<pubDate>Thu, 26 Jul 2007 11:39:17 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:17:12</itunes:duration>
			<itunes:keywords>AIDS, HIV, adolescents, young adults, efavirenz, tenofovir, emtricitabine, atazanavir, lopinavir, fosamprenavir, ritonavir, zidovudine, lamivudine, didanosine, contraception, pregnancy, pill burden, adherence, simplification, nevirapine, abacavir</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - HIV in Young Adults: An Often Overlooked Epidemic</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA03540FCCMEInfo.pdf" length="119655" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03540FCCMEInfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03540FCCMEInfo.pdf</guid>
			<pubDate>Thu, 26 Jul 2007 11:38:57 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, adolescents, young adults, efavirenz, tenofovir, emtricitabine, atazanavir, lopinavir, fosamprenavir, ritonavir, zidovudine, lamivudine, didanosine, contraception, pregnancy, pill burden, adherence, simplification, nevirapine, abacavir</itunes:keywords>
		</item>
		<item>
			<title>Sally L. Hodder, MD - Updated Data from Los Angeles: The Impact of HIV and HIV Therapies on Metabolic Outcomes</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, experts in the treatment of HIV present recent data on the effects of antiretrovirals on metabolic and body-composition parameters. Cohort data on HIV and cardiovascular risk and emerging management strategies for dyslipidemia in HIV are featured. </description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present recent data on the effects of antiretrovirals on metabolic and body-composition parameters. Cohort data on HIV and cardiovascular risk and emerging management strategies for dyslipidemia in HIV are featured. </itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA03538FC1s389.m4v" length="22499765" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03538FC1s389.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03538FC1s389.m4v</guid>
			<pubDate>Thu, 17 May 2007 08:44:05 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:19:45</itunes:duration>
			<itunes:keywords>AIDS, HIV, metabolic, lipids, cholesterol, triglycerides, HDL, LDL, cardiovascular, body composition, atazanavir, efavirenz, lopinavir, fosamprenavir, tenofovir, stavudine, zidovudine, ezetimibe, leptin, BMS-089, ACTG-5142, SMART, D:A:D, ACTG 5095, KLEAN</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information Updated Data from Los Angeles: The Impact of HIV and HIV Therapies on Metabolic Outcomes</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA03538FC1CMEinfo.pdf" length="107265" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03538FC1CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03538FC1CMEinfo.pdf</guid>
			<pubDate>Thu, 17 May 2007 08:43:36 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, metabolic, lipids, cholesterol, triglycerides, HDL, LDL, cardiovascular, body composition, atazanavir, efavirenz, lopinavir, fosamprenavir, tenofovir, stavudine, zidovudine, ezetimibe, leptin, BMS-089, ACTG-5142, SMART, D:A:D, ACTG 5095, KLEAN</itunes:keywords>
		</item>
		<item>
			<title>Calvin Cohen, MD, MSc  - Re-evaluating Treatment Goals and Prognosis in Treatment-Experienced Patients with HIV</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, experts in the treatment of HIV use case-based scenarios to evaluate management strategies for treatment-experienced patients with HIV. </description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV use case-based scenarios to evaluate management strategies for treatment-experienced patients with HIV. </itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA03695FC2r281.m4v" length="43188296" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03695FC2r281.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03695FC2r281.m4v</guid>
			<pubDate>Thu, 03 May 2007 16:34:44 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:38:46</itunes:duration>
			<itunes:keywords>AIDS, HIV, persistent low level viremia, treatment-experienced, treatment goals, viral suppression, efavirenz, atazanavir, fosamprenavir, lopinavir, saquinavir, tenofovir, darunavir, tenofovir, emtricitabine, nevirapine, ritonavir, DHHS, IAS-USA</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Re-evaluating Treatment Goals and Prognosis in Treatment-Experienced Patients with HIV</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA03695FC2CMEinfo.pdf" length="277051" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03695FC2CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03695FC2CMEinfo.pdf</guid>
			<pubDate>Thu, 03 May 2007 15:03:54 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, persistent low level viremia, treatment-experienced, treatment goals, viral suppression, efavirenz, atazanavir, fosamprenavir, lopinavir, saquinavir, tenofovir, darunavir, tenofovir, emtricitabine, nevirapine, ritonavir, DHHS, IAS-USA</itunes:keywords>
		</item>
		<item>
			<title>William A. O&apos;Brien - Understanding Implications of Updated Guidelines for Initiating Antiretroviral Therapy</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, experts in the treatment of HIV review the most recent guidelines for the initiation of antiretroviral therapy in HIV. Data used as evidence for some of the updated recommendations will be featured.</description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV review the most recent guidelines for the initiation of antiretroviral therapy in HIV. Data used as evidence for some of the updated recommendations will be featured.</itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA03620FC1r302.m4v" length="22884091" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03620FC1r302.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03620FC1r302.m4v</guid>
			<pubDate>Fri, 27 Apr 2007 16:24:03 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:19:55</itunes:duration>
			<itunes:keywords>HIV, AIDS, DHHS, IAS-USA, guidelines, efavirenz, atazanavir, lopinavir, saquinavir, darunavir, tipranavir, tenofovir, emtricitabine, lamivudine, 3TC, abacavir, zidovudine, nevirapine, fosamprenavir, treatment naïve, treatment-experienced</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Understanding Implications of Updated Guidelines for Initiating Antiretroviral Therapy</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA03620FC1CMEinfo.pdf" length="267183" />
			<link>http://podcast.peerviewpress.com/aids/PA03620FC1CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03620FC1CMEinfo.pdf</guid>
			<pubDate>Fri, 27 Apr 2007 15:29:39 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>HIV, AIDS, DHHS, IAS-USA, guidelines, efavirenz, atazanavir, lopinavir, saquinavir, darunavir, tipranavir, tenofovir, emtricitabine, lamivudine, 3TC, abacavir, zidovudine, nevirapine, fosamprenavir, treatment naïve, treatment-experienced</itunes:keywords>
		</item>
		<item>
			<title>Calvin Cohen, MD, MSc - Achieving Viral Suppression for Treatment-Experienced Patients</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, experts in the treatment of HIV present the most current data on the importance of optimum viral suppression for the management of treatment-experienced patients with HIV. The consequences of persistent low-level viremia are featured.</description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present the most current data on the importance of optimum viral suppression for the management of treatment-experienced patients with HIV. The consequences of persistent low-level viremia are featured.</itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/aidsvideo/PA03695FC1r280.m4v" length="52026846" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03695FC1r280.m4v</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03695FC1r280.m4v</guid>
			<pubDate>Tue, 24 Apr 2007 12:02:02 -0400</pubDate>
			<category>Science &amp; Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:45:58</itunes:duration>
			<itunes:keywords>AIDS, HIV, treatment-experienced, resistance, HIV RNA, viral load, DHHS, IAS-USA, enfuvirtide, darunavir, tipranavir, ritonavir, lopinavir, saquinavir, amprenavir, fosamprenavir, efavirenz, TMC125, TMC114, maraviroc, vicriviroc, MK-0518, GS9137, integrase</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Achieving Viral Suppression for Treatment-Experienced Patients</title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aidsvideo/PA03695FC1CMEinfo.pdf" length="279207" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03695FC1CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aidsvideo/PA03695FC1CMEinfo.pdf</guid>
			<pubDate>Tue, 24 Apr 2007 12:01:58 -0400</pubDate>
			<category>Science &amp; Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, AIDS, HIV</itunes:keywords>
		</item>
		<item>
			<title>Eric S. Daar, MD - Advances in Fixed-Dose Antiretroviral Therapy in HIV </title>
			<itunes:author>PeerView Press</itunes:author>
			<description>In this activity, experts in the treatment of HIV present recent data on efficacy and safety of fixed-dose antiretrovirals. The incorporation of many of these agents into evidence-based guidelines is featured. </description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present recent data on efficacy and safety of fixed-dose antiretrovirals. The incorporation of many of these agents into evidence-based guidelines is featured. </itunes:summary>
			<enclosure type="video/x-m4v" url="http://www.podtrac.com/pts/redirect.m4v?http://podcast.peerviewpress.com/AIDSVideo/r275.m4v" length="34662888" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03525FC1r275.m4v</link>
			<guid>http://podcast.peerviewpress.com/AIDSVideo/r275.m4v</guid>
			<pubDate>Fri, 16 Mar 2007 09:28:17 -0400</pubDate>
			<category>Science &amp; Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:30:49</itunes:duration>
			<itunes:keywords>HIV, AIDS, fixed-dose, FDCs, zidovudine, lamivudine, efavirenz, tenofovir, emtricitabine, abacavir, NRTI, NNRTI, lopinavir, ritonavir, atazanavir, adherence, patient satisfaction, DHHS, IAS-USA, fixed-dose combination</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Advances in Fixed-Dose Antiretroviral Therapy in HIV </title>
			<itunes:author>PeerView Press</itunes:author>
			<description>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file.</description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/AIDSVideo/PA03525FC1CMEinfo.pdf" length="123819" />
			<link>http://podcast.peerviewpress.com/AIDSVideo/PA03525FC1CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/AIDSVideo/PA03525FC1CMEinfo.pdf</guid>
			<pubDate>Fri, 16 Mar 2007 08:27:51 -0400</pubDate>
			<category>Science &amp; Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>HIV, AIDS, fixed-dose, FDCs, zidovudine, lamivudine, efavirenz, tenofovir, emtricitabine, abacavir, NRTI, NNRTI, lopinavir, ritonavir, atazanavir, adherence, patient satisfaction, DHHS, IAS-USA, fixed-dose combination</itunes:keywords>
		</item>
	</channel>
</rss>